Fintel reports that on November 7, 2025, HC Wainwright & Co. maintained coverage of Amylyx Pharmaceuticals (NasdaqGS:AMLX) ...
The average one-year price target for Amylyx Pharmaceuticals (NasdaqGS:AMLX) has been revised to $20.74 / share. This is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback